Bellevue Group AG - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 296 filers reported holding BLUEBIRD BIO INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2020$910,000
-43.3%
19,800
+8.2%
0.02%
-28.0%
Q4 2019$1,606,000
-30.6%
18,300
+0.5%
0.02%
-37.5%
Q2 2019$2,315,000
-36.3%
18,200
-21.2%
0.04%
-80.0%
Q1 2019$3,634,000
+183.9%
23,100
+79.1%
0.20%
+138.1%
Q4 2018$1,280,000
-23.1%
12,900
+13.2%
0.08%
-20.8%
Q3 2018$1,664,000
-17.8%
11,400
-11.6%
0.11%
-38.7%
Q2 2018$2,025,000
-10.8%
12,900
-3.0%
0.17%
-23.1%
Q1 2018$2,271,000
-33.2%
13,300
-30.4%
0.22%
-36.6%
Q4 2017$3,402,000
-1.3%
19,100
-23.9%
0.36%
-1.7%
Q3 2017$3,447,000
+48.4%
25,100
+13.6%
0.36%
+31.3%
Q2 2017$2,322,000
-11.9%
22,100
-23.8%
0.28%
-21.7%
Q1 2017$2,636,000
+47.3%
29,0000.0%0.35%
-4.1%
Q4 2016$1,789,000
-9.0%
29,0000.0%0.37%
+3.1%
Q3 2016$1,966,000
+56.7%
29,0000.0%0.36%
+50.4%
Q2 2016$1,255,000
+1.8%
29,0000.0%0.24%
+5.4%
Q1 2016$1,233,00029,0000.22%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,335,528$40,104,0004.92%
qPULA Trading Management LP 14,344$91,0000.80%
Frazier Life Sciences Management, L.P. 1,440,757$9,120,0000.70%
Ikarian Capital, LLC 462,628$2,928,0000.58%
Birchview Capital, LP 98,000$620,0000.44%
HealthCor Management, L.P. 455,000$2,880,0000.36%
Financial Advocates Investment Management 45,071$3,538,0000.29%
PDT Partners, LLC 262,767$1,663,0000.25%
Monaco Asset Management SAM 80,000$506,0000.19%
Summit X, LLC 103,424$651,0000.19%
View complete list of BLUEBIRD BIO INC shareholders